HomePharma

Pharma

Pharma

UroGen Announces FDA Clearance of IND Application for the Investigational Immunotherapy UGN-301 (zalifrelimab) Intravesical Solution in Recurrent Non-Muscle Invasive Bladder Cancer

Life Sciences Times - 0
Pharma

Alzamend Neuro Announces Full Data Set From Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s

Life Sciences Times - 0
Pharma

First Patient Dosed in CAN106 Phase 1b/2 Trial for Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in China

Life Sciences Times - 0
Pharma

Ipsen Receives Positive CHMP Opinion for Cabometyx® in Radioactive Iodine-refractory Differentiated Thyroid Cancer

Life Sciences Times - 0
Pharma

Angelini Pharma, a New Partner in Epilepsy

Life Sciences Times - 0
Pharma

Bristol Myers Squibb Announces New Prescription Drug User Fee Act Goal Date for Reblozyl® (luspatercept-aamt) Supplemental Biologics License Application

Life Sciences Times - 0
Pharma

Cyclica and Arctoris to Expand Partnership to Advance Drug Discovery Programs for Alzheimer’s Disease

Life Sciences Times - 0
Pharma

Virpax Completes All FDA-Required Pre-Clinical Studies for Epoladerm™

Life Sciences Times - 0
Pharma

physIQ and CellCarta Collaborate to Accelerate a More Precise, Personalized Approach to Vaccine Development

Life Sciences Times - 0
Pharma

Propanc Biopharma’s CEO Believes Proenzyme Therapy May Become the Healthcare Solution of Choice for Treating Cancerous Solid Tumors

Life Sciences Times - 0
Pharma

LinKinVax Announces a Collaboration With GTP Bioways for the Development and Production of Its Second-generation Vaccine Against SARS-CoV-2

Life Sciences Times - 0
Pharma

JSR Life Sciences’ Amsphere A3 Integrated into the Commercial Manufacturing of FDA-Approved Antibody Therapy

Life Sciences Times - 0
1...575859...91Page 58 of 91

Most Read